Establishing Comparable Requirements and Treatment Groups Before Applying Statistical Comparison Reply

被引：2
作者：
Chatterjee, Saurav [1 ]
Sardar, Partha [2 ]
Biondi-Zoccai, Giuseppe [3 ]
Kumbhani, Dharam J. [4 ]
机构：
[1] St Lukes Roosevelt Hosp, Div Cardiol, Mt Sinai Hlth Syst, New York, NY 10025 USA
[2] New York Med Coll, Metropolitan Hosp Ctr, Dept Med, New York, NY 10029 USA
[3] Univ Roma La Sapienza, Dept Medicosurg Sci & Biotechnol, Latina, Italy
[4] Univ Texas Southwestern, Div Cardiol, Dallas, TX USA
来源：
JAMA NEUROLOGY | 2014年 / 71卷 / 03期
关键词：
ATRIAL-FIBRILLATION; WARFARIN;
D O I：
10.1001/jamaneurol.2013.6003
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：371 / 372
页数：2
相关论文
共 7 条
[1]   Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes [J].
Bloomfield, Hanna E. ;
Krause, Ange ;
Greer, Nancy ;
Taylor, Brent C. ;
MacDonald, Roderick ;
Rutks, Indulis ;
Reddy, Preetham ;
Wilt, Timothy J. .
ANNALS OF INTERNAL MEDICINE, 2011, 154 (07) :472-482
[2]   New Oral Anticoagulants and the Risk of Intracranial Hemorrhage Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Biondi-Zoccai, Giuseppe ;
Kumbhani, Dharam J. .
JAMA NEUROLOGY, 2013, 70 (12) :1486-1490
[3]   Apixaban in Patients with Atrial Fibrillation [J].
Connolly, Stuart J. ;
Eikelboom, John ;
Joyner, Campbell ;
Diener, Hans-Christoph ;
Hart, Robert ;
Golitsyn, Sergey ;
Flaker, Greg ;
Avezum, Alvaro ;
Hohnloser, Stefan H. ;
Diaz, Rafael ;
Talajic, Mario ;
Zhu, Jun ;
Pais, Prem ;
Budaj, Andrzej ;
Parkhomenko, Alexander ;
Jansky, Petr ;
Commerford, Patrick ;
Tan, Ru San ;
Sim, Kui-Hian ;
Lewis, Basil S. ;
Van Mieghem, Walter ;
Lip, Gregory Y. H. ;
Kim, Jae Hyung ;
Lanas-Zanetti, Fernando ;
Gonzalez-Hermosillo, Antonio ;
Dans, Antonio L. ;
Munawar, Muhammad ;
O'Donnell, Martin ;
Lawrence, John ;
Lewis, Gayle ;
Afzal, Rizwan ;
Yusuf, Salim .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) :806-817
[4]   Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden [J].
Davidson, Thomas ;
Husberg, Magnus ;
Janzon, Magnus ;
Oldgren, Jonas ;
Levin, Lars-Ake .
EUROPEAN HEART JOURNAL, 2013, 34 (03) :177-183
[5]   Current and new oral antithrombotics in nonvalvular atrial fibrillation: a network meta-analysis of 79 808 patients [J].
Dogliotti, Ariel ;
Paolasso, Ernesto ;
Giugliano, Robert P. .
HEART, 2014, 100 (05) :396-405
[6]   WARFARIN IN THE PREVENTION OF STROKE ASSOCIATED WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
EZEKOWITZ, MD ;
BRIDGERS, SL ;
JAMES, KE ;
CARLINER, NH ;
COLLING, CL ;
GORNICK, CC ;
KRAUSESTEINRAUF, H ;
KURTZKE, JF ;
NAZARIAN, SM ;
RADFORD, MJ ;
RICKLES, FR ;
SHABETAI, R ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (20) :1406-1412
[7]   New Oral Anticoagulants Are Not Superior to Warfarin in Secondary Prevention of Stroke or Transient Ischemic Attacks, but Lower the Risk of Intracranial Bleeding: Insights from a Meta-Analysis and Indirect Treatment Comparisons [J].
Sardar, Partha ;
Chatterjee, Saurav ;
Wu, Wen-Chih ;
Lichstein, Edgar ;
Ghosh, Joydeep ;
Aikat, Shamik ;
Mukherjee, Debabrata .
PLOS ONE, 2013, 8 (10)
1